当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2007年第18期
编号:282784
P选择素与糖尿病肾病
http://www.100md.com 2007年10月27日 《中国医药导报》 2007年第18期
     [9]Devaraj S, Chan AV Jr, Jialal I,et al.Alpha-tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients[J].Diabetes Care, 2002, 25: 524-529.

    [10]Wang ZY, Shi JM, Han Y,et al.Comparative study of platelet activationmarker in diabetes mellitus patients complicated by cerebrovasculardisease[J].Blood Coagul Fibrinol,2001,12(7):531-537.

    [11]Yngen M, Ostenson CG, Hu H,et al.Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetesmellitus and microangiopathy:evidence for platelet hyperactivity and chronic inflammation[J].Diabetologia,2004,47(3):537-540.

    [12]Nozaki M, Ogura Y, Hirabayashi Y,et al.Enhanced expresion of adhesion molecules of the retinal vascular endothelium in spontaneous diabetic rats[J].Ophthalmic Res,2002,34(3):158-164.

    [13]Sassy-Prigent C,Heudes D,Mandet C,et al.Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats[J].Diabetes,2000,49(3):466-475.

    [14]Naji Y,Amol B,Neal K,et al.Platelet abnormalities in diabetes mellitus[J].Coronary Artery Disease,2003,14(5):365-371.

    [15]Guijarro C,Egido J.Transcription factor-κB(NF-κB)and renal disease[J]. Kidney Int,2001,59(2):415-424.

    [16]王红漫,邓华聪,刘万星,等.对氧磷酯酶-1和氧化低密度脂蛋白在2型糖尿病肾病中的作用[J].中华内科杂志,2002,41(3):179-182.

    (收稿日期:2007-03-26)

    “本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”。, 百拇医药(王 辉 甘 华)
  • 查看PDF全文